Cantor Fitzgerald analyst Carter Gould raised the price target on Eli Lilly (NYSE: LLY) to $1,205.00 (from $985.00) while maintaining a Overweight rating.

Analyst PT Change

Truist: 'Defending Lilly: LLY strong position helps guard their share in a crowded GLP-1 landscape'February 5, 2026 12:35 PM Wells Fargo on Eli Lilly (LLY): 'Compounders Strike Again, but We See Little Risk to Near-Term Growth'February 5, 2026 10:10 AM